Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by canadapieton Feb 01, 2021 2:56pm
113 Views
Post# 32438803

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Thank you

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Thank youI did the same + wrote about examples of capital increase done by other companies way better for existing shareholders..........! No answer yet.


Scarlet:
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Thank you
Great we want proactive company we need to be proactive too I have sent many emails to IR too and don't care if she refuses to respond."bugging Theratechnologies mode".
Bucknelly21 wrote:

sent this to Phillipe 


You guys have not participated in the bubble beside from taking easy money in what appears to be a really bad deal for long term shareholders and a great deal for banks who appear to keeping the market warrants and selling everything else. I hope I’m wrong. I hate to say it but it’s true, no real value for shareholders other that hope one of the things in the pipeline works out. The playing everything close to the chest strategy has not worked when luc was there and is not working now. Try mixing it up a little, it certainly can’t hurt the markets view of the company because it appears the market doesn’t buy into anything that’s happening behind the closed doors.


<< Previous
Bullboard Posts
Next >>